# Human Chorionic Gonadotrophin in an Antagonist Protocol

> **NCT01833858** · PHASE2,PHASE3 · COMPLETED · sponsor: **Cairo University** · enrollment: 60 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Low dose HCG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01833858
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-10
- **Final completion:** 2015-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01833858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01833858, "Human Chorionic Gonadotrophin in an Antagonist Protocol". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01833858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*